Welcome to CaliforniaLifeScience.com
CaliforniaLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 5,000 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
More...
Learn about Sacramento's Embarcadero Road Biotech/Medical Device Facility
The Embarcadero Road biotech/medical device facility, located just off Riverside Parkway and Interstate 80, ecompasses
425,146 square feet on 9.76 Acres. This unique facility offers office, laboratory, manufacturing, and assembly space, plus
cleanrooms to address your every need. This facility is located in a state designated Enterprise Zone, and the West Sacrament
Redevelopment Area/Targeted Employment Zone providing additional incentives and benefits for your company.
Learn about biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in California, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- U.S. to provide antiviral medication to Latin America and the Caribbean for H1N1 influenza HHS Secretary Kathleen Sebelius announced that the United States will provide 420,000 treatment courses of Tamiflu (Oseltamavir) to the Pan-American Health Organization (PAHO) to fight the novel H1N1 influenza in Latin America and the Caribbean.
Dept. of Health & Human Services July 02, 2009
- Phase III study showed Lucentis improved vision in branch retinal vein occlusion Genentech announced that the Phase III study BRAVO showed Lucentis(R) (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion.
Genentech Inc. July 02, 2009
- FDA approves Multaq to treat heart rhythm disorder The U.S. Food and Drug Administration has approved Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders).
FDA July 02, 2009
- Johnson & Johnson and Elan Corporation announce definitive agreement Johnson & Johnson and Elan Corporation announced a definitive agreement whereby Johnson & Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP Program), through a newly formed company.
Johnson & Johnson July 02, 2009
- Illumina launches multi-sample indexing for GoldenGate(R) Assay Illumina launched GoldenGate Indexing, a high-throughput genotyping solution that utilizes multi-sample indexing technology. Researchers may now screen up to 16 times as many samples per reaction as the standard GoldenGate Assay.
Illumina, Inc. July 02, 2009
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
ORCA Monthly Meeting - July 9: Register now!
More... |
Submit Event |
Event Advertising...
|
|
Learn About California's BioHistory

Why is there a biotechnology industry in California? Will the industry continue
to grow in California? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through California BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of California.
More...
BioEvolution Posters
More...
June is National Safety Month

National Safety Month is the NSC’s annual campaign to educate people about some of our nation’s leading causes of
preventable deaths and injuries.
The National Safety Council saves lives by preventing injuries and deaths at work, in homes and
communities, and on the roads, through leadership, research, education and advocacy.
More...
BioFact
(1979) - Seeds of the Earth, a book by Canadian economist Pat Mooney, is the first publication to warn of potential control of germplasm resources by the private sector, launching an international debate over the control and use of genetic resources.
It's a Small World
|
| |
Organic Cells
| |
Science Quote
"One thing that makes the adventure of working in our field particularly rewarding, especially in attempting to improve the theory, is that... a chief criterion for the selection of a correct hypothesis... seems to be the criterion of beauty, simplicity, or elegance."
| - |
Murray Gell-Mann - U. S. Physicist (Nobel Prize, 1969)
|
|
(1929- )
|
|